http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009041565-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14f8866fd10a12d3cc3afb0e2240920d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edfa1ddd389451f4b101bf67fbca62c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2008-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774d285921bab4d34b935d2018c14755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b1f8ead9e492d4283139f40686d250
publicationDate 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009041565-A1
titleOfInvention Quinazolinone derivative, and prophylactic or therapeutic agent for corneal/conjunctival disorder comprising quinazolinone derivative as active ingredient
abstract A compound represented by the general formula (I) or a salt thereof exhibits excellent prophylactic and ameliorating effect on an age-related corneal disorder or the like in a pharmacological test using SAMP10, and is therefore useful as a prophylactic or therapeutic agent for a corneal/conjunctival disorder such as dry eye, superficial punctate keratitis and corneal epithelial defect. In the general formula (I), A1-A2 represents a group 1; X represents a group 2 or the like; Y represents a carbon atom or a nitrogen atom; a dashed line represents a single bond or a double bond; L represents a single bond, an alkylene group, a cycloalkenylene group or the like; R1a and R1b independently represent a hydrogen atom, a halogen atom or the like; R2 represents a hydrogen atom or a halogen atom; and R3 represents a hydrogen atom or a halogen atom.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9062061-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013008872-A1
priorityDate 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005009398-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0077197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03063874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005082079-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03007959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03080581-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135408753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129044479

Total number of triples: 46.